For the details of NEA Management Company, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/nea+management+company%2C+llc/current-portfolio/portfolio
These are the top 5 holdings of NEA Management Company, LLC- Elastic NV (ESTC) - 5,562,153 shares, 23.14% of the total portfolio. New Position
- Ra Pharmaceuticals Inc (RARX) - 6,138,797 shares, 7.16% of the total portfolio.
- Rhythm Pharmaceuticals Inc (RYTM) - 4,912,306 shares, 7.01% of the total portfolio.
- GlycoMimetics Inc (GLYC) - 9,089,041 shares, 5.90% of the total portfolio.
- Allakos Inc (ALLK) - 2,268,188 shares, 4.78% of the total portfolio.
NEA Management Company, LLC initiated holding in Elastic NV. The purchase prices were between $64.01 and $99.07, with an estimated average price of $83.31. The stock is now traded at around $83.45. The impact to a portfolio due to this purchase was 23.14%. The holding were 5,562,153 shares as of .
New Purchase: Millendo Therapeutics Inc (MLND)NEA Management Company, LLC initiated holding in Millendo Therapeutics Inc. The purchase prices were between $7.65 and $15, with an estimated average price of $11.28. The stock is now traded at around $16.55. The impact to a portfolio due to this purchase was 1.38%. The holding were 1,766,779 shares as of .
Added: Mersana Therapeutics Inc (MRSN)NEA Management Company, LLC added to a holding in Mersana Therapeutics Inc by 46.04%. The purchase prices were between $3.51 and $7.3, with an estimated average price of $5.02. The stock is now traded at around $5.60. The impact to a portfolio due to this purchase was 1.03%. The holding were 11,894,267 shares as of .
Added: Nightstar Therapeutics PLC (NITE)NEA Management Company, LLC added to a holding in Nightstar Therapeutics PLC by 70.00%. The purchase prices were between $11.52 and $25.54, with an estimated average price of $17.5. The stock is now traded at around $25.45. The impact to a portfolio due to this purchase was 0.66%. The holding were 1,214,285 shares as of .
Added: Genocea Biosciences Inc (GNCA)NEA Management Company, LLC added to a holding in Genocea Biosciences Inc by 39.79%. The purchase prices were between $0.29 and $0.9, with an estimated average price of $0.61. The stock is now traded at around $0.72. The impact to a portfolio due to this purchase was 0.3%. The holding were 34,948,269 shares as of .
Added: Trillium Therapeutics Inc (TRIL)NEA Management Company, LLC added to a holding in Trillium Therapeutics Inc by 68.00%. The purchase prices were between $0.6 and $2, with an estimated average price of $1.24. The stock is now traded at around $0.57. The impact to a portfolio due to this purchase was 0.03%. The holding were 2,100,000 shares as of .
Sold Out: Tesaro Inc (TSRO)NEA Management Company, LLC sold out a holding in Tesaro Inc. The sale prices were between $74.02 and $74.96, with an estimated average price of $74.7.
Sold Out: Millendo Therapeutics Inc (3OS1)NEA Management Company, LLC sold out a holding in Millendo Therapeutics Inc. The sale prices were between $6.31 and $12.93, with an estimated average price of $9.77.
Here is the complete portfolio of NEA Management Company, LLC. Also check out:
1. NEA Management Company, LLC's Undervalued Stocks
2. NEA Management Company, LLC's Top Growth Companies, and
3. NEA Management Company, LLC's High Yield stocks
4. Stocks that NEA Management Company, LLC keeps buying